Brief: Quest PharmaTech Announces Sale Of Bioceltran Investment And Return Of Photodynamic Therapy Technology License
28/09/2022 22:00
Sept 28 (Reuters) - Quest Pharmatech Inc QPT.V :
* QUEST PHARMATECH ANNOUNCES SALE OF BIOCELTRAN INVESTMENT
AND
RETURN OF PHOTODYNAMIC THERAPY TECHNOLOGY LICENSE
Source text for Eikon: ID:nCNWlQ2wla
Further company coverage: QPT.V
Recent news on Quest PharmaTech
See all newsBrief: Quest Pharmatech Announces Change Of Chief Executive Officer
Brief: Quest Pharmatech Provides Product Development Update
Brief: Quest PharmaTech Clarifies Agreement in Principle with OQP Bio
Brief: Quest Pharmatech Provides Corporate Update
Brief: Quest PharmaTech Announces Sale Of Bioceltran Investment And Return Of Photodynamic Therapy Technology License